Diphenhydramine IM Dosing for Allergic Reactions

Adult Dosing

The American College of Physicians recommends the standard parenteral dose of diphenhydramine for adults is 25-50 mg per dose for allergic reactions, with diphenhydramine considered a second-line therapy after epinephrine in anaphylaxis management and should never be administered alone 1

The American Academy of Pediatrics recommends weight-based dosing for children is 1-2 mg/kg per dose, with a maximum single dose of 50 mg 1

The American Medical Association recommends parenteral administration is preferred for faster onset of action in acute allergic reactions, with the onset of action for diphenhydramine being several minutes when given parenterally, and a duration of effect of 4-6 hours 1

The American Heart Association recommends first administering epinephrine for anaphylactic reactions, followed by diphenhydramine as adjunctive therapy, with adults receiving 25-50 mg IM and children receiving 1-2 mg/kg IM (not exceeding 50 mg per dose) 2, 3, 4, 1
The American College of Allergy, Asthma, and Immunology recommends considering adding an H2-antagonist, such as ranitidine, as the combination of diphenhydramine and ranitidine is superior to diphenhydramine alone for urticaria 4
The Society of Critical Care Medicine recommends administering corticosteroids, such as hydrocortisone 200 mg IV for adults, to prevent protracted or biphasic reactions 2, 3

The American Academy of Emergency Medicine recommends diphenhydramine should never replace epinephrine as the first-line treatment for anaphylaxis, and common adverse effects include dizziness, blurred vision, dry mouth, hypotension, and urinary retention, with hypnotic effects increased when combined with alcohol, benzodiazepines, or opioid narcotics 1

Oral liquid formulations of diphenhydramine are absorbed more rapidly than tablets, particularly important in acute allergic reactions, according to the American Academy of Allergy, Asthma, and Immunology 5

For anaphylaxis management, the American Academy of Allergy, Asthma, and Immunology recommends administering epinephrine IM (0.3 mg for adults >25 kg) as first-line treatment, followed by diphenhydramine 50 mg IV or oral as adjunctive therapy 5
The American Academy of Allergy, Asthma, and Immunology suggests considering H2-antagonist (ranitidine 75-150 mg) for superior urticaria control, and adding corticosteroids (prednisone 60-80 mg oral or methylprednisolone 60-80 mg IV) to prevent biphasic reactions, with supportive care including albuterol for bronchospasm, IV fluids for hypotension, and supplemental oxygen 5